Vaccine and Treatment Evaluation Units (VTEU)
- Funded by National Institutes of Health (NIH)
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
20202022Known Financial Commitments (USD)
$5,921,655Funder
National Institutes of Health (NIH)Principal Investigator
PendingResearch Location
United States of AmericaLead Research Institution
BAYLOR COLLEGE OF MEDICINEResearch Priority Alignment
N/A
Research Category
Vaccines research, development and implementation
Research Subcategory
Phase 3 clinical trial
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Clinical Trial, Phase III
Broad Policy Alignment
Pending
Age Group
Adults (18 and older)
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
ABSTRACTThis supplement request is for a Phase 3, randomized, stratified, observer-blind, placebo-controlled study to evaluate the efficacy, safety and immunogenicity, of mRNA-1273 vaccinecompared to placebo in adults 18 years of age and older who have no known history of SARS-CoV-2 infection but whose locations or circumstances put them at appreciable risk of acquiringCOVID-19 and/or SARS-CoV-2 infection. This request also relates to other COVID 19 activities.